Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion…
Read More »
The Memorandum of Understanding includes the formation of a Joint…
Definitive agreement to accelerate adoption of Renalytix’s FDA-approved, Medicare reimbursed…
KUDA THERAPEUTICS AWARDED $5.6M U.S. DoD GRANT TO BRING LEAD…
ARUP Achieves Reaccreditation Under College of American Pathologists ISO 15189…
Study will begin enrollment in Q1 2026 in the US…
Owlet’s new release creates the ultimate baby monitoring system for…
BioUtah Member Appreciation BBQ 2025 Recap
Kimbell & Associates: Trump Administration Issues MAHA Strategy Report of…
If approved, ZORYVE cream would be the first and only…
Salt Lake City Angels Invests in Freyya
The wearable baby monitor trusted by millions globally expands reach…
Dr. Gordon Ringold to advise on various strategies related to…
BD Expands Peripheral Artery Disease Awareness Efforts with ‘Love Your…
Renowned leaders in neurology, movement disorders, and commercialization join to…
Generic Saxenda® is the first-ever generic GLP-1 indicated for weight…
Halia Therapeutics Published in Journey of Drug Targeting
The Company filed a substantial non-provisional PCT patent application seeking…
Epic Ventures Gains $200M Fresh Capital
Canyon Labs Opens Expanded Facility
Notifications
